BAXTER INTERNATIONAL INC's gross profit margin for the fourth quarter of its fiscal year 2015 has decreased when compared to the same period a year ago. Sales and net income fell significantly, underperforming compared to the average company in its industry.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q4 FY15||Q4 FY14|
|Net Sales ($mil)||2603.0||4472.0|
|Net Income ($mil)||205.0||953.0|
|Balance Sheet||Q4 FY15||Q4 FY14|
|Cash & Equiv. ($mil)||0.0||2925.0|
|Total Assets ($mil)||0.0||25917.0|
|Total Debt ($mil)||0.0||9305.0|
|Profitability||Q4 FY15||Q4 FY14|
|Gross Profit Margin||41.14||54.76|
|Return on Assets||0.0||9.63|
|Return on Equity||0.0||10.51|
|Debt||Q4 FY15||Q4 FY14|
|Share Data||Q4 FY15||Q4 FY14|
|Shares outstanding (mil)||546.82||542.38|
|Div / share||0.12||0.52|
|Book value / share||0.0||14.97|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||4646566.0||6731416.0|
BUY. BAXTER INTERNATIONAL INC's P/E ratio indicates a discount compared to an average of 56.45 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 20.99. The price-to-sales ratio is above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, BAXTER INTERNATIONAL INC proves to trade at a discount to investment alternatives within the industry.
|BAX 53.45||Peers 56.45||BAX NA||Peers 26.83|
Average. An average P/E ratio can signify an industry neutral price for a stock and an average growth expectation.
BAX is trading at a valuation on par with its peers.
Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.
Ratio not available.
|BAX 22.34||Peers 21.24||BAX NM||Peers 1.77|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
BAX is trading at a premium to its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
BAX's negative PEG ratio makes this valuation measure meaningless.
|BAX NA||Peers 4.15||BAX -54.20||Peers -13.75|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
Ratio not available.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, BAX is expected to significantly trail its peers on the basis of its earnings growth rate.
|BAX 2.08||Peers 5.70||BAX -19.63||Peers 18.39|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
BAX is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
BAX significantly trails its peers on the basis of sales growth
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.